Siebert, Stefan http://orcid.org/0000-0002-1802-7311
Behrens, Frank
Lubrano, Ennio
Martin, Nicolas
Sharaf, Mohamed
Contré, Christine
Theander, Elke
Queiro, Rubén
Zimmermann, Miriam
Gossec, Laure
Clinical trials referenced in this document:
Documents that mention this clinical trial
AB0438 BASELINE CHARACTERISTICS OF REAL-WORLD PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB OR IL-17 INHIBITORS: RESULTS FROM THE ONGOING MULTINATIONAL PSABIOND STUDY
https://doi.org/10.1136/annrheumdis-2024-eular.1860
PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis
https://doi.org/10.1007/s40744-022-00518-w
Funding for this research was provided by:
Janssen
Article History
Received: 7 October 2022
Accepted: 30 November 2022
First Online: 30 December 2022